Home

Funding Opportunities Specific to COVID-19

This page contains a listing of active and expired funding opportunities specific to Coronavirus Disease 2019 (COVID-19).

On This Page:

Active Funding Opportunities

Title Notice Number Organization(s) Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Research on Gender Measurement (Admin Supp Clinical Trial Optional) NOT-OD-23-046 ORWH, NCI, NIA, NIAID, NICHD, NIDA, NIMHD, NLM, SGMRO Jan 24, 2023 Mar 1, 2023 333
Research Centers in Minority Institutions (RCMI) (U54 Clinical Trial Optional) RFA-MD-23-001 NIMHD Jan 3, 2023 Mar 2, 2023 U54
Notice of Special Interest (NOSI): Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases NOT-AR-23-008 NIAMS Dec 29, 2022 Jan 8, 2024 R01, R21
Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI) NOT-MD-23-001 NIMHD, NIDA, ORWH Dec 20, 2022 Mar 3, 2023 333
Notice of Special Interest (NOSI): Research Supplements to Promote Data Science Workforce Diversity to Reveal Scientific Insights of COVID-19 Testing Technologies (Admin Supp Clinical Trial Not Allowed) NOT-OD-23-041 OD, NIA, NICHD, NIDA, NIDCR, NIMH, NIMHD, NINR, NLM Dec 19, 2022 Feb 20, 2023 333
Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21) NOT-OD-23-040 OD, NIA, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIMH, NIMHD, NLM, ORWH Dec 19, 2022 May 31, 2023 R21
Notice of Special Interest (NOSI): Research on Gender Measurement (Admin Supp Clinical Trial Optional) NOT-OD-23-029 ORWH, NCI, NIA, NIAID, NIDA, NIMHD, NLM, SGMRO Dec 5, 2022 Mar 1, 2023 333
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed) RFA-HD-24-006 NICHD, NIMH Nov 22, 2022 Mar 30, 2023 R21
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed) RFA-DA-24-002 NIDA Nov 15, 2022 Mar 24, 2023 R61/R33
Cooperative Centers on Human Immunology (U19 Clinical Trial Optional) RFA-AI-22-069 NIAID Nov 14, 2022 Apr 8, 2023 U19
Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) NOT-OD-22-208 ORWH, NCCIH, NCI, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, PN, SGMRO Sep 7, 2022 Feb 1, 2023 333
Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes NOT-DA-23-008 NIDA, NCCIH, NIA, NIAAA Aug 3, 2022 Sep 8, 2025 R61/R33
Notice of Special Interest (NOSI): Studies of Cellular/Molecular Pathobiological Mechanisms of Lung Diseases Using Human 3-Dimensional Cellular Systems (R01) NOT-HL-22-030 NHLBI Jul 5, 2022 Sep 8, 2025 R01
Notice of Special Interest (NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition Insecurity NOT-OD-22-135 ONR, FIC, NCI, NHLBI, NIAMS, NICHD, NIDCR, NIDDK, NIMH, NIMHD, NINR, OAR, OBSSR, ODP, ODS, PN, ORWH Jun 21, 2022 Nov 29, 2024 R01, 333, R21, K01, R34, R33, R61/R33, UG3/UH3, K43
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) PAR-22-167 NCATS, NIAMS, NICHD, NIDCR, NIGMS, NIMHD, OBSSR, ORWH May 9, 2022 Oct 18, 2024 UG3/UH3
Notice of Special Interest: Research on Alcohol and Coronavirus Disease (COVID-19) within the Mission of NIAAA NOT-AA-22-012 NIAAA Apr 29, 2022 Mar 6, 2024 R01, R03, R21, K99/R00
Notice of Special Interest (NOSI) - Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities NOT-HD-22-003 NICHD, NIAAA, NIDA, NINDS, OBSSR, ORWH Apr 19, 2022 Jun 6, 2024 333
Notice of Special Interest (NOSI) - Emerging and Existing Issues of Coronavirus Disease 2019 (COVID-19) Research Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities NOT-HD-22-002 NICHD, NIDA, NIEHS, NINDS, OBSSR, ORWH Mar 28, 2022 Jun 6, 2024 R01, R21
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) PAR-22-138 NIMH, NIAAA, NIEHS, ORWH Mar 15, 2022 May 8, 2025 R21
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) PAR-22-137 NIMH, NIAAA, NIEHS, ORWH Mar 15, 2022 May 8, 2025 R01
Notice of Special Interest (NOSI): Addressing Accessibility Inequities with COVID Home-Based Testing for Individuals with Visual Impairment NOT-EY-22-010 NEI Feb 4, 2022 Mar 9, 2024 R41/R42, R15, 333, R01, R43/R44, R21
Notice of Special Interest (NOSI): Research on barriers to care and risk of HIV-associated comorbidities among vulnerable population groups NOT-HL-22-010 NHLBI Jan 31, 2022 May 8, 2025 R01
Notice of Special Interest (NOSI): COVID-19 Pandemic Mental Health Research NOT-MH-22-100 NIMH Jan 19, 2022 Jan 8, 2025 R21, R34, R01
Notice of Special Interest (NOSI): COVID-19 Pandemic Mental Health Research NOT-MH-22-100 NIMH Jan 19, 2022 Jan 8, 2025 R21, R34, R01
Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection NOT-HL-22-004 NHLBI, NICHD, NIAID Dec 21, 2021 Sep 8, 2025 R01, R21
Notice of Special Interest: Administrative Supplements and Urgent Competitive Revisions on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA NOT-AA-22-002 NIAAA Dec 2, 2021 May 8, 2024 333
Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations NOT-MH-21-330 NIMH, NEI, ODP, SGMRO, NIDA, OBSSR, NIAAA, NINR, NIDCR, NIMHD, ORWH, NICHD, NIDCD, NIA, NCCIH Aug 20, 2021 Sep 8, 2024 R01, UG3/UH3
Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations NOT-MH-21-330 NIMH, NEI, ODP, SGMRO, NIDA, OBSSR, NIAAA, NINR, NIDCR, NIMHD, ORWH, NICHD, NIDCD, NIA, NCCIH Aug 20, 2021 Sep 8, 2024 R01, UG3/UH3
Notice of Special Interest (NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilities NOT-HD-21-038 NICHD Jun 28, 2021 May 8, 2024 R03, R21
Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide NOT-AI-21-057 NIAID, NIMH, NIDA Jun 25, 2021 May 8, 2024 R01, R21
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs NOT-TR-21-022 NCATS Feb 26, 2021 Aug 17, 2024 333
Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration NOT-AG-21-016 NIA Feb 26, 2021 May 8, 2023 R01, R21, R03
Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders NOT-DA-21-019 NIDA Feb 10, 2021 Sep 8, 2024 R01, R03, R21
Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19 NOT-DA-21-017 NIDA Feb 4, 2021 Sep 8, 2024 R01, R03, R21
Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders NOT-DA-21-018 NIDA Feb 3, 2021 Sep 8, 2024 R01, R03, R21
Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs NOT-TR-21-017 NCATS Feb 3, 2021 Aug 17, 2024 333
Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) NOT-DE-21-001 NIDCR Jan 26, 2021 May 8, 2023 R01, R21
Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection NOT-DA-21-011 NIDA Jan 26, 2021 Sep 8, 2024 R01, R03, R21
Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research NOT-MH-21-120 NIMH Dec 23, 2020 Jun 2, 2023 333
Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) NOT-HL-20-814 NHLBI Sep 15, 2020 Jul 6, 2024 R01
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities NOT-MD-20-025 NIMHD, NCI, NIDA, NLM, ODP, OBSSR, NIMH, NIAMS Aug 13, 2020 May 8, 2023 R01
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) PA-20-135 NIH, NCATS, NCCIH, NCI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINR, NLM, ORWH, OSC Mar 10, 2020 Sep 8, 2025 333

Expired Funding Opportunities

Title Notice Number Organization(s) Release
Date		 Expiration
Date		 Activity
Code(s)
Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Cohort Study Sites for Pediatric Follow Up. Clinical Trial Not Allowed (UG3/UH3) RFA-OD-22-019 OD, NCATS, NCCIH, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINDS, NINR, NLM, OBSSR, ODP, ORWH Aug 30, 2022 Nov 22, 2022 UG3/UH3
Limited Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy and Pediatric Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3) RFA-OD-22-018 OD, NCATS, NCCIH, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINDS, NINR, NLM, OBSSR, ODP, ORWH Aug 30, 2022 Nov 22, 2022 UG3/UH3
Maintaining Immunity after Immunization (U01 Clinical Trial Not Allowed) RFA-AI-22-055 NIAID Aug 22, 2022 Jan 14, 2023 U01
Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed) RFA-DK-22-016 NIDDK Jul 13, 2022 Dec 21, 2022 U01
Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional) PAR-22-203 NIBIB, FIC, NCCIH, NCI, NHLBI, NIAID, NIDA Jul 13, 2022 Jan 8, 2023 U54
Notice of Special Interest (NOSI): Administrative Supplements to NIMHD Awards for Research on HIV/AIDS in Populations that Experience Health Disparities (Admin Supp Clinical Trial Optional) NOT-MD-22-022 NIMHD Jun 30, 2022 Aug 1, 2022 333
Notice of Special Interest (NOSI): COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs NOT-NS-23-001 NINDS, NIA Jun 21, 2022 Aug 12, 2022 333
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed) RFA-DA-23-052 NIDA Jun 13, 2022 Aug 11, 2022 U24
NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional) RFA-HD-23-026 NICHD May 23, 2022 Sep 9, 2022 P01
Notice of Special Interest: Administrative Supplements to Advance Precision Medicine Using the All of Us Research Programs Data NOT-PM-22-002 OD, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OAR, OBSSR, ODSS, ORWH, RM, SGMRO May 20, 2022 Jul 6, 2022 333
NICHD Maternal-Fetal Medicine Units (MFMU) Network: Data Coordinating Center (U24 Clinical Trial Optional) RFA-HD-23-017 NICHD May 6, 2022 Aug 12, 2022 U24
Policy and Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed) RFA-AG-23-024 NIA May 6, 2022 Oct 21, 2022 R01
Notice of Special Interest (NOSI): IMPROVE Initiative: Implementation Science to Advance Maternal Health and Maternal Health Equity NOT-OD-22-125 OD May 5, 2022 Jul 17, 2022 R01,R03,R21
Notice of Special Interest (NOSI): Administrative Supplements to Support "All of US" and Health Disparities-Related Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI) NOT-MD-22-015 NIMHD May 3, 2022 Jun 28, 2022 333
Emergency Award: Rapid Acceleration of Diagnostics Tribal Data Repository (RADx TDR) (U24 Clinical Trial Not Allowed) RFA-OD-22-011 OD, NIA, NIAMS, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM Apr 6, 2022 Jun 1, 2022 U24
Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities NOT-ES-22-005 NIEHS Mar 29, 2022 Jun 7, 2022 333
Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities NOT-ES-22-005 NIEHS Mar 29, 2022 Jun 7, 2022 333
Notice of Intent to Publish a Funding Opportunity Announcement for Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed) NOT-DK-22-018 NIDDK Mar 23, 2022 n/a
Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional) RFA-MD-22-008 NIMHD, NCI Mar 22, 2022 Nov 14, 2022 R01
Emergency Awards: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional) RFA-OD-22-005 OD, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR Feb 17, 2022 May 3, 2022 U01
Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional) RFA-OD-22-006 OD, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR Feb 17, 2022 May 3, 2022 U01
Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required) PAR-22-112 NIMH Jan 31, 2022 Dec 24, 2022 R01
Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required) PAR-22-112 NIMH Jan 31, 2022 Dec 24, 2022 R01
Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional) PAR-22-113 NIMH Jan 31, 2022 Dec 24, 2022 R01
Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) RFA-NR-22-001 NINR, NIDA, NIMH, NIMHD, OBSSR, ODP Jan 25, 2022 Apr 8, 2022 R01
HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed) RFA-DE-22-011 NIDCR, NCATS, NCCIH, NCI, NIA, NIAMS, NICHD Jan 21, 2022 Apr 1, 2022 R21
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies NOT-GM-22-026 NIGMS Jan 21, 2022 Mar 22, 2022 333
Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy NOT-HL-23-003 NHLBI Jan 21, 2022 Jul 6, 2022 R01
Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases NOT-AR-22-012 NIAMS Dec 28, 2021 Jan 8, 2023 R21,R01
Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities NOT-MD-22-006 NIMHD, ODP, NIDA, NIAID, SGMRO, NIMH, ORWH, NINR, NCI, NIDCR, OBSSR Dec 21, 2021 Jan 8, 2023 R01
Notice of Intent to Publish a Funding Opportunity Announcement for Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) NOT-NR-22-004 NINR, NIMH, ODP, OBSSR, NIDA, NIMHD Dec 17, 2021 n/a
Notice of Special Interest (NOSI): Availability of Administrative Supplements for Research on Pathobiological Mechanisms of Post-Acute Sequelae of SARS-CoV-2 Infection NOT-OD-22-038 OD, ORWH, NCI, NIA, NIAAA, NIADD, NIAID, NIAMS, NIGMS, NCATS, NEI, NHGRI, NHLBI, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NINDS, NIMHD, NINR, NLM, ODP, ORIP, NCCIH, NIMH Dec 7, 2021 Jan 25, 2022 333
Notice of Special Interest (NOSI): Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional) NOT-OD-22-030 ORWH, NIDA, NEI, NIDCD, NIEHS, NHGRI, NIMH, NIAID, NINR, NICHD, NHLBI, NCCIH, NIAAA, SGMRO, NCATS, NIDCR, NIAMS, ORIP, NIDDK, NIBIB, NIA Dec 2, 2021 Jan 27, 2023 333
Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI) NOT-MD-22-001 NIMHD, NIDA Oct 25, 2021 Feb 2, 2022 333
Impact of Technology and Digital Media (TDM) Exposure/Usage on Child and Adolescent Development (P01 Clinical Trial Optional) RFA-HD-22-009 NICHD Aug 25, 2021 Nov 30, 2021 P01
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) PAR-21-276 NIAID Jul 16, 2021 Jul 16, 2022 S10
Notice of Special Interest (NOSI): Competitive Revision and Administrative Supplements to Existing NICHD HIV Grants and Cooperative Agreements to Understand HIV Health Impacts of COVID-19 NOT-HD-21-037 NICHD Jul 2, 2021 May 8, 2022 333
Notice of Special Interest (NOSI): Administrative Supplements to NIMHD Awards for Research on HIV/AIDS in Populations that Experience Health Disparities (Admin Supp Clinical Trial Optional) NOT-MD-21-020 NIMHD May 27, 2021 Jul 16, 2021 333
Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional) RFA-DA-22-001 NIDA Apr 27, 2021 Aug 14, 2021 R43/R44
Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus NOT-DA-21-041 NIDA Apr 15, 2021 Mar 31, 2022 333
Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional) RFA-OD-21-009 NIH, NLM, NIAID, ECHO, NICHD, NCI, NCATS, NCCIH, NEI, NHLBI, NHGRI, NIAMS, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, NIA, NIAAA, NIDCD, NIDA, NIMHD, OBSSR, ODP, ORWH, SGMRO, THRO, NIBIB Apr 13, 2021 Jul 8, 2021 U01
Notice of Special Interest (NOSI): Administrative Supplements for Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) Phase I Projects to Address Vaccine Hesitancy and Uptake NOT-OD-21-101 NIH, NIMH, NIDDK, NICHD, NCI, NCATS, NCCIH, NHLBI, NIEHS, NIGMS, NINR, NIA, NIAAA, NIDA, NIMHD, NLM, NIAID Apr 13, 2021 May 4, 2021 333
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional) NOT-OD-21-103 NIH, NIDCD, ECHO, NICHD, NCI, NCATS, NCCIH, NEI, NHLBI, NHGRI, NIAID, NIAMS, NIBIB, NIDCR, NIEHS, NIGMS, NIMH, NINDS, NINR, NIA, NIAAA, NIDA, NIMHD, NLM, OBSSR, ODP, ORWH, SGMRO, THRO, NIDDK Apr 13, 2021 May 25, 2021 U01
Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional) RFA-OD-21-008 NIH, NIBIB, NIDDK, NIEHS, NIMH, NINDS, NINR, NIA, NIAAA, NIDCD, NIDA, NIMHD, NLM, OBSSR, ODP, SGMRO, THRO, NIDCR, NHLBI, ECHO, NICHD, NCI, NCATS, NCCIH, NEI, NHGRI, NIAID, NIAMS, NIGMS, ORWH Apr 13, 2021 Jul 8, 2021 U01
Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium Coordinating Center (U24 Clinical Trial Not Allowed) RFA-AG-21-035 NIA, ORWH, OBSSR Apr 8, 2021 Jun 10, 2021 U24
Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) PAR-21-213 NIA, NEI, NIAAA, NIDA, NIMH, NIMHD, NINR, OBSSR, ORWH Apr 6, 2021 Nov 9, 2021 U01
Notice of Special Interest (NOSI): Administrative Supplements to FIC Awards for COVID-19-related Research in Low- or Middle-Income Countries NOT-TW-21-004 FIC Mar 23, 2021 May 15, 2021 333
Notice of Special Interest (NOSI): Administrative Supplements for COVID-19-Impacted FIC Research Training and Education Awards NOT-TW-21-003 FIC Mar 23, 2021 May 15, 2021 333
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiative (Phase II) NOT-OD-21-064 NIH, ORWH Mar 22, 2021 n/a
Notice of Special Interest: Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populations NOT-NS-21-037 NINDS Mar 15, 2021 May 6, 2021 333
Notice of Special Interest: Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populations NOT-NS-21-037 NINDS Mar 15, 2021 May 6, 2021 333
Notice of Special Interest (NOSI): Administrative Supplements to SEPA Awards to Develop Innovative Educational Resources to Address SARS-CoV-2 Vaccine Hesitancy NOT-GM-21-032 NIGMS Mar 10, 2021 May 1, 2021 333
Notice of Special Interest (NOSI): Administrative Supplements to SEPA Awards to Develop Innovative Educational Resources to Address SARS-CoV-2 Vaccine Hesitancy NOT-GM-21-032 NIGMS Mar 10, 2021 May 1, 2021 333
Notice of Special Interest (NOSI): Administrative Supplements and Urgent Competitive Revisions for NIH Grants to Add or Expand Research Focused on Maternal Health, Structural Racism and Discrimination, and COVID-19 NOT-OD-21-071 NIH Mar 5, 2021 Apr 14, 2021 333
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy NOT-GM-21-021 NIGMS, SGMRO Mar 1, 2021 May 1, 2021 333
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy NOT-GM-21-021 NIGMS, SGMRO Mar 1, 2021 May 1, 2021 333
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 NOT-GM-21-019 NIGMS Feb 25, 2021 Dec 16, 2021 333
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 NOT-GM-21-019 NIGMS Feb 25, 2021 Dec 16, 2021 333
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies NOT-GM-21-031 NIGMS Feb 18, 2021 Apr 1, 2021 333
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) RFA-AA-21-003 NIAAA Feb 5, 2021 Aug 18, 2021 R03
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) RFA-AA-21-003 NIAAA Feb 5, 2021 Aug 18, 2021 R03
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) RFA-AA-21-002 NIAAA Feb 5, 2021 Aug 18, 2021 R01
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) RFA-AA-21-002 NIAAA Feb 5, 2021 Aug 18, 2021 R01
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) RFA-AA-21-004 NIAAA Feb 5, 2021 Aug 18, 2021 R21
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed) RFA-AA-21-004 NIAAA Feb 5, 2021 Aug 18, 2021 R21
Notice of Special Interest (NOSI): Complement in Basic Immunology (CIBI) NOT-AI-21-008 NIAID Feb 4, 2021 Jan 8, 2023 R01,R21
Notice of Special Interest (NOSI): Urgent Competitive Revisions and Administrative Supplements for Research at NIMHD Research Centers in Minority Institutions (RCMI U54s) on SARS-CoV-2 Vaccine Hesitancy, Uptake, and Implementation NOT-MD-21-012 NIMHD Feb 4, 2021 May 4, 2021 333
Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Study the Impact of COVID-19 on Global Cancer Prevention and Control NOT-CA-21-033 NCI Feb 3, 2021 Apr 1, 2021 333
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed) NOT-AA-21-003 NIAAA Jan 27, 2021 Feb 28, 2021
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed) NOT-AA-21-003 NIAAA Jan 27, 2021 Feb 28, 2021
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trials Not Allowed) NOT-AA-21-002 NIAAA Jan 27, 2021 Feb 3, 2021
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed) NOT-AA-21-001 NIAAA Jan 27, 2021 Feb 28, 2021
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed) NOT-AA-21-001 NIAAA Jan 27, 2021 Feb 28, 2021
Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19) NOT-AG-21-015 NIA Jan 26, 2021 Sep 10, 2021 R01,R03,R21,U19,P01,R21/R33
Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed) RFA-AI-20-078 NIAID, NICHD, NIEHS Jan 12, 2021 Jun 19, 2021 U19
Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) RFA-AI-20-077 NIAID, NICHD, NIEHS Jan 12, 2021 Jun 19, 2021 U01
Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases NOT-AR-21-012 NIAMS Jan 5, 2021 Nov 19, 2021 R01,R21
RESCINDED - Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities NOT-MD-21-008 NIMHD, NCI, NHLBI, NIAAA, NIAID, NIAMS, NIDCR, NIMH, NINR, OBSSR, ODP, ORWH Dec 17, 2020 Jan 8, 2022 R01
Notice of Special Interest (NOSI): Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs NOT-TR-21-011 NCATS Dec 17, 2020 Jun 2, 2021 333
Notice of Special Interest (NOSI): Urgent Competitive Revisions for Research on Critical Threats to Public Health in Large-Scale Population Cohorts NOT-HG-21-020 NHGRI Dec 10, 2020 Jan 16, 2021 333
Notice of Intent to Publish a Funding Opportunity Announcement for Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities NOT-MD-21-007 NIMHD Dec 7, 2020 Dec 31, 2020
Limited Competition for Emergency Competitive Revisions For Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 from Skin and the Oral Cavity for Rapid Acceleration of Diagnostics Radical (RADx-rad) NOT-OD-21-035 NIH, NIDCR, NHLBI Nov 25, 2020 Dec 5, 2020 333
Notice of Special Interest: Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) NOT-OD-21-020 NIH, NLM, NIEHS, NIAMS, NIDCR, OBSSR, NIGMS, NHLBI, NCI, NIAAA, NINR, NCATS, ORWH, NHGRI, FIC, NCCIH, NIMH, THRO, NIDA, NINDS, NEI, NIMHD, NIAID, NIA, FDA, NIBIB, NIDCD, NICHD, NIDDK Nov 17, 2020 Mar 5, 2021 333
Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities NOT-ES-21-002 NIEHS Nov 17, 2020 Dec 30, 2020 333
Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities NOT-ES-21-002 NIEHS Nov 17, 2020 Dec 30, 2020 333
Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects NOT-AI-21-002 NIAID Nov 10, 2020 Jun 12, 2021 P01
RESCINDED - Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection NOT-DA-20-084 NIDA Oct 27, 2020 Jan 26, 2021 R01,R03,R21
Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) NOT-TR-21-006 NCATS Oct 23, 2020 Mar 17, 2021 UH2,U34,U01
Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) NOT-TR-21-006 NCATS Oct 23, 2020 Mar 17, 2021 UH2,U34,U01
Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 NOT-AI-20-065 NIAID Aug 13, 2020 Mar 15, 2021 U01
Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional) RFA-OD-20-023 NIH, FIC, NCATS, NHLBI, NIAID, NIAMS, NICHD, NIDA, NIMHD Aug 6, 2020 Oct 1, 2020 R61/R33
Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional) RFA-OD-20-022 NIH, NIA, NIDCD, ORWH, NICHD, NLM, NINR, NINDS, NIDCR Aug 6, 2020 Sep 16, 2020 U01
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed) RFA-OD-20-021 NIH, NIAAA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCR Aug 6, 2020 Sep 19, 2020 R42
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed) RFA-OD-20-020 NIH, NIAAA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCR Aug 6, 2020 Sep 19, 2020 R44
Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) RFA-OD-20-019 NIH, NIAAA, NIA, NCCIH, NIDCD, NIDDK, NIEHS, NIGMS, NICHD, NIMHD, NLM, NINR, NCATS, OBSSR, NHLBI, NIDCR, NIDA Aug 6, 2020 Oct 1, 2020 U24
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) RFA-OD-20-018 NIH, NIA, NCI, RM, NCATS, NHLBI, NIDCR, NIDA, NHGRI Aug 6, 2020 Sep 19, 2020 U18
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) RFA-OD-20-018 NIH, NIA, NCI, RM, NCATS, NHLBI, NIDCR, NIDA, NHGRI Aug 6, 2020 Sep 19, 2020 U18
Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed) RFA-OD-20-017 NIH, NIAAA, NIA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCR Aug 6, 2020 Sep 19, 2020 U18
Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional) RFA-OD-20-016 NIH, NIAAA, NIDDK, NIGMS, NIMHD, NLM, NINR, OBSSR, NIDCR, NIDA Aug 6, 2020 Oct 1, 2020 R01
Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed) RFA-OD-20-015 NIH, NIEHS, NIGMS, NLM, NIDA Aug 6, 2020 Sep 16, 2020 U01
Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed) RFA-OD-20-014 NIH, NIAAA, NIA, NCCIH, NCI, NICHD Aug 6, 2020 Sep 16, 2020 U01
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool NOT-OD-20-152 NIH, NIA, NIDCD, ORWH, NICHD, NINR, NINDS, NIDCR Aug 6, 2020 Sep 16, 2020 333
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19). NOT-OD-20-159 NIH, NLM Aug 6, 2020 Aug 22, 2020 333
Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) RFA-TR-20-003 NCATS Aug 5, 2020 Jan 24, 2021 U01
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) PAR-20-256 NIAID Jul 13, 2020 Jul 8, 2021 S10
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-rad Initiative NOT-OD-20-144 NIH, NIDCD Jul 10, 2020 Aug 6, 2020
Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) RFA-DK-20-021 NIDDK Jul 10, 2020 Dec 17, 2020 R01
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-AI-20-059 NIAID Jul 6, 2020 Jul 2, 2021 333
Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) NOT-CA-20-082 NCI Jul 6, 2020 Aug 15, 2020 333
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) PAR-20-243 NIMH, NCCIH, NEI, NIA, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIMHD, NINR, OBSSR, ODP, ORWH Jun 25, 2020 Mar 3, 2021 R01
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project NOT-OD-20-129 NIH, NCATS, NCCIH, NCI, NHGRI, NHLBI, NIAID, NIAMS, NICHD, NIDCD, NIDCR, NIDDK, NIEHS, NIMHD, NINDS, ORIP Jun 25, 2020 Jul 13, 2021 333
Request for Proposals (RFP) Solicitation S20-119: Serological Sciences Network Capacity Building Centers NOT-CA-20-077 NCI Jun 25, 2020 Jul 31, 2020
Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) PAR-20-237 NIMHD, NIDCD, NIMH, ODP, NINR, NIA, SGMRO, NIDDK, NIEHS, NICHD, NCATS, ORWH, NIAAA, NCCIH, NIDA, NEI, NIDCR Jun 17, 2020 Dec 2, 2020 R01
Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need NOT-TR-20-029 NCATS Jun 15, 2020 Nov 11, 2020 333
NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) PAR-20-234 NIA Jun 15, 2020 Feb 2, 2021 R01
Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations NOT-OD-20-121 NIH, NIDCR, NICHD, NCI, NCATS, NEI, NHLBI, NIAID, NIAMS, NIDDK, NIEHS, NIGMS, NHGRI, NIMH, NINDS, NINR, NIAAA, NIDA, NIMHD, ORWH, OBSSR, NLM, SGMRO, THRO, NIA, NCCIH, ODP Jun 12, 2020 Aug 8, 2020 333
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations NOT-OD-20-120 NIH, NIAID, NIBIB, NIDCR, NIMHD, NICHD, NIAMS, FIC, NCI, NCATS, NCCIH, NEI, NHLBI, NIDDK, NIEHS, NIGMS, NHGRI, NIMH, NINDS, NINR, NIAAA, NIA, NIDCD, NIDA, ORWH, OBSSR, ODP, NLM, SGMRO, THRO Jun 12, 2020 Sep 9, 2020 333
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations NOT-OD-20-119 NIH, NICHD, FIC, NCI, NCATS, NCCIH, NEI, NHLBI, NIAID, NIAMS, NIBIB, NIDCR, NIDDK, NIEHS, NIGMS, NHGRI, NIMH, NINDS, NINR, NIA, NIAAA, NIDA, NIMHD, ORWH, ODP, NLM, SGMRO, THRO, NIDCD, OBSSR Jun 12, 2020 Sep 9, 2020 333
Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) RFA-OD-20-013 NIH, NCI, NIAMS, NIA, NICHD, FIC, NCATS, NCCIH, NEI, NHLBI, NIBIB, NIDCR, NIEHS, NIGMS, NHGRI, NIMH, NINR, NIDCD, NIDA, NIMHD, ORWH, OBSSR, NLM, SGMRO, THRO, ODP Jun 12, 2020 Aug 8, 2020 U24
Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) RFA-CA-20-038 NCI, NIAID Jun 5, 2020 Jul 23, 2020 U54
Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) RFA-CA-20-039 NCI, NIAID Jun 5, 2020 Jul 23, 2020 U01
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations NOT-MD-20-022 NIMHD, ORWH, NCATS, NCCIH, NEI, NHLBI, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, OBSSR, ODP Jun 5, 2020 Dec 30, 2020 333
Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 NOT-MH-20-053 NIMH, NCATS, NCCIH, NEI, NHLBI, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NINR, OBSSR, ODP, ORWH Jun 5, 2020 Dec 30, 2020 333
Notice of Intent to Publish a Funding Opportunity Announcement for Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 - Clinical Trial Optional) NOT-MH-20-058 NIMH, NIAAA, NIA, NCCIH, NIDCD, NICHD, NINR, OBSSR, ODP, NIDCR, NIDA, NEI Jun 4, 2020 Jun 26, 2020
Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders NOT-DC-20-008 NIDCD Jun 4, 2020 Sep 8, 2022 R01,R21,R41/R42,R43/R44
Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) NOT-MD-20-023 NIMHD, NIDCD, OBSSR, NIDA, NINR, ODP, NCCIH, NIMH, NIDCR, NIEHS, NIA, NICHD, ORWH Jun 3, 2020 Jun 17, 2020
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives NOT-OD-20-112 NIH May 29, 2020 Jun 26, 2020
Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for Coronavirus Disease 2019 (COVID-19) related Research NOT-OD-20-107 NIH May 27, 2020 Jun 30, 2020 333
Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) NOT-AT-20-012 NCCIH May 26, 2020 Aug 18, 2020 333
NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional) RFA-RM-20-020 RMOD May 21, 2020 Oct 1, 2020 R01
NIH Directors Emergency Early Independence Awards (DP5 Clinical Trial Optional) RFA-RM-20-021 RMOD May 21, 2020 Sep 5, 2020 DP5
Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-AI-20-051 NIAID May 19, 2020 Sep 8, 2020 R03,R43/R44,R41/R42
Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence NOT-CA-20-066 NCI May 15, 2020 Jun 5, 2020
Notice of Special Interest (NOSI):? Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR NOT-DE-20-022 NIDCR, ORWH May 5, 2020 Nov 3, 2020 333
Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network NOT-DE-20-023 NIDCR May 1, 2020 Nov 3, 2020 X01
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System NOT-NS-20-051 NINDS Apr 30, 2020 Apr 15, 2021 333
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) PAR-20-177 NIAID Apr 30, 2020 Aug 14, 2020 R21
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) PAR-20-178 NIAID Apr 30, 2020 Aug 14, 2020 R01
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials NOT-HL-20-782 NHLBI Apr 27, 2020 Oct 6, 2020 333
Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21) NOT-LM-20-011 NLM Apr 27, 2020 Jun 17, 2020 R21
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-RM-20-015 RMOD Apr 27, 2020 Jun 20, 2020 333
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs NOT-TR-20-028 NCATS Apr 23, 2020 Nov 11, 2020 333
Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA NOT-AA-20-011 NIAAA Apr 16, 2020 Apr 16, 2021 333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) NOT-LM-20-010 NLM Apr 16, 2020 Jun 2, 2020 333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences NOT-OD-20-097 OBSSR, NCCIH, NCI, NHGRI, NHLBI, NIAAA, NICHD, NIDDK, NIEHS, NINR, ODP, ORWH Apr 13, 2020 Apr 1, 2021 333
Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) NOT-ES-20-020 NIEHS Apr 10, 2020 May 4, 2021 333,R21
Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) NOT-EB-20-007 NIBIB Apr 10, 2020 Aug 29, 2020 R01,R21,R03
Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 NOT-GM-20-027 NIGMS Apr 10, 2020 May 6, 2020 333
NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) NOT-ES-20-017 NIEHS Apr 10, 2020 Apr 25, 2020 333
Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) NOT-EB-20-006 NIBIB Apr 10, 2020 Sep 6, 2020 R41/R42,R43/R44
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) NOT-EB-20-008 NIBIB Apr 10, 2020 Aug 29, 2020 333
Notice of Special Interestregarding the Availability of Administrative Supplements and Urgent Competitive Revisions for the Establishment and Maintenance of a Research Database for Neurological Manifestations of the SARS-CoV-2 NOT-NS-20-046 NINDS Apr 10, 2020 May 9, 2020 333
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission NOT-DK-20-020 NIDDK Apr 9, 2020 Jun 2, 2020 333
Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities NOT-MD-20-019 NIMHD, NIAAA, NIMH, ODP Apr 9, 2020 May 1, 2021 333
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus NOT-TR-20-017 NCATS Apr 9, 2020 Jan 26, 2022 333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus NOT-MH-20-047 NIMH, NIAAA, ODP Apr 9, 2020 Apr 16, 2021 333
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus NOT-TR-20-016 NCATS Apr 9, 2020 Jan 26, 2022 333
Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19) NOT-CA-20-043 NCI Apr 9, 2020 Jun 26, 2020 333
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK NOT-DK-20-018 NIDDK Apr 9, 2020 Jun 2, 2020 333
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) NOT-DC-20-004 NIDCD Apr 9, 2020 Jun 2, 2020 333
Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) NOT-AT-20-011 NCCIH, NIA, NIAAA, ODP Apr 9, 2020 Oct 7, 2020 333
Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) NOT-CA-20-042 NCI Apr 9, 2020 Jun 26, 2020 333
Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) NOT-ES-20-015 NIEHS Apr 8, 2020 May 4, 2021 333,R21
Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) NOT-AG-20-022 NIAAA, NIMH Apr 2, 2020 May 1, 2021 333
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus NOT-HG-20-030 NHGRI Mar 31, 2020 May 16, 2020 333
Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) NOT-TR-20-012 NCATS Mar 27, 2020 Oct 17, 2020 UH2,U01,U34
RESCINDED - Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-AI-20-031 NIAID Mar 27, 2020 Apr 5, 2021 R03,R21,333,R01,R43/R44,R41/R42
RESCINDED - Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) NOT-ES-20-014 NIEHS Mar 27, 2020 Apr 25, 2020 333
RESCINDED - Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-AI-20-034 NIAID Mar 25, 2020 Jul 6, 2020 333
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 NOT-GM-20-025 NIGMS Mar 25, 2020 Feb 6, 2021 333
Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need NOT-TR-20-011 NCATS Mar 24, 2020 Jul 10, 2021 333,U01,R21,U54
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus NOT-DA-20-047 NIDA Mar 19, 2020 Mar 31, 2021 333
RESCINDED - Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) NOT-HL-20-757 NHLBI Mar 17, 2020 May 15, 2020 333
RESCINDED - Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) NOT-AI-20-030 NIAID, NIGMS Feb 6, 2020 Apr 8, 2020 333
Notice of Special Interest: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) NOT-OD-20-048 ORWH, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD Dec 13, 2019 Jan 26, 2021 333
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) RFA-OD-19-029 ORWH, NCCIH, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIDA, NIDCR, NIEHS, NIMH, NINR Sep 27, 2019 Nov 27, 2021 R01


Technical Issues: E-mail OER Webmaster   




  • National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892

  • NIH... Turning Discovery Into Health